Vorinostat and metformin sensitize EGFR-TKI resistant NSCLC cells via BIM-dependent apoptosis induction

There is a close relationship between low expression of BIM and resistance to epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Vorinostat is a pan-histone deacetylase inhibitor (HDACi) that augments BIM expression in various types of tumor cells, however, this effect is attenua...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hengyi, Wang, Yubo, Lin, Caiyu, Lu, Conghua, Han, Rui, Jiao, Lin, Li, Li, He, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706838/
https://www.ncbi.nlm.nih.gov/pubmed/29212192
http://dx.doi.org/10.18632/oncotarget.21225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706838/
https://www.ncbi.nlm.nih.gov/pubmed/29212192
http://dx.doi.org/10.18632/oncotarget.21225

Ejemplares similares